Related Experiment Videos
Molecular mechanisms of resistance to taxanes and therapeutic implications
Franco Zunino1, Giuliana Cassinelli, Donatella Polizzi
1Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, 20133, Italy
Abstract:
The mechanism of resistance to taxanes has not been fully elucidated. Since Taxol is a substrate for P-glycoprotein, overexpression of this transport system is recognized as a relevant mechanism of resistance. Additional mechanisms include changes of microtubule structure and/or composition resulting in reduced drug binding to the target. Current efforts are directed at clarifying the role of cellular response to drug-induced damage to cytoskeleton and mitotic spindle. Downstream events, such as control of cell cycle progression and regulation of cell death pathways, are likely to play a relevant role in cellular sensitivity to antimicrotubule agents. The identification of resistance factors and critical determinants of antitumor efficacy of microtubule-stabilizing agents is essential to (i) improve their therapeutic efficacy; and (ii) to design non-cross-resistant compounds. The present review discusses the possible therapeutic implications of the recent progress in the field of resistance to taxanes. Copyright 1999 Harcourt Publishers Ltd.
Insights
Mechanisms of taxane resistance are complex, involving P-glycoprotein and altered microtubule structure. Understanding these factors is key to improving cancer treatment efficacy and designing new drugs.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Taxanes are crucial chemotherapy agents, but their efficacy is limited by drug resistance.
- P-glycoprotein (P-gp) overexpression is a known mechanism conferring resistance to taxanes like Taxol.
- Other resistance mechanisms involve alterations in microtubule structure and cellular responses to drug-induced damage.
Purpose of the Study:
- To review and elucidate the multifaceted mechanisms of taxane resistance.
- To discuss the role of cellular pathways in sensitivity to antimicrotubule agents.
- To highlight the importance of identifying resistance factors for therapeutic advancement.
Main Methods:
- Literature review of existing research on taxane resistance mechanisms.
- Analysis of cellular responses to taxane-induced damage.
- Discussion of downstream events in cell cycle and cell death pathways.
Main Results:
- P-glycoprotein overexpression is a significant contributor to taxane resistance.
- Changes in microtubule structure and composition reduce drug efficacy.
- Cellular responses to cytoskeleton damage and mitotic spindle disruption play a critical role.
Conclusions:
- Further research into taxane resistance mechanisms is essential for improving cancer therapy.
- Identifying resistance factors will enable the design of more effective, non-cross-resistant taxane analogs.
- Understanding these mechanisms is vital for enhancing the therapeutic efficacy of microtubule-stabilizing agents.